Mainolfi Nello
Reporting owner on Forms 3, 4 and 5, CIK 1821189.
Mainolfi Nello reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-01.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| Kymera Therapeutics, Inc. CIK 1815442 | director, officer (Chief Executive Officer) | 1 | 2026-10-01 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. Common Stock | 2026-10-01 | M exercised | +30,000 | $2.08 | 696,568 | Form 4 |
| Kymera Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -3,525 | $111.44 | 693,043 | Form 4 |
| Kymera Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -5,506 | $112.42 | 687,537 | Form 4 |
| Kymera Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -4,876 | $113.24 | 682,661 | Form 4 |
| Kymera Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -7,601 | $114.43 | 675,060 | Form 4 |
| Kymera Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -8,230 | $115.4 | 666,830 | Form 4 |
| Kymera Therapeutics, Inc. Common Stock | 2026-10-01 | S sold | -262 | $116.12 | 666,568 | Form 4 |
| Kymera Therapeutics, Inc. Stock Option (Right to Buy), derivative | 2026-10-01 | M exercised | -30,000 | $0 | 60,000 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001193125-26-410839 | Kymera Therapeutics, Inc. | 2026-10-01 |